Company Information
USD
0.55
- (-%)
NASDAQ:MRNS, MARINUS PHARMACEUTICALS, INC.
Industry: Biotechnology
End of Day: 11 February 2025 GMT-4
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.
Address
100 Matsonford Road
Suite 500, 5 Radnor Corporate Center
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Timothy M. Mayleben
Director
Mr. Elan Ezickson
Director
Mr. Seth H.Z. Fischer
Director
Dr. Scott Braunstein, M.D.
CEO/Chairman of the Board/Director/President
Dr. Sarah B. Noonberg, M.D.,PhD
Director
Ms. Christine Berni Silverstein
Director
Mr. Charles Austin
Director
Mr. Marvin H. Johnson, Jr
Director
Dr. Saraswathy V. Nochur, PhD
Director
Mr. Steven Pfanstiel, C.M.A.,M.B.A.
CFO/Chief Accounting Officer/COO/Treasurer/Vice President
Ms. Martha E. Manning, Esq.
General Counsel/Secretary/Vice President
Mr. Joseph Hulihan
Chief Medical Officer
Ms. Christina Shafer
Other Executive Officer
Ownership
Institution Holdings
Suvretta Capital Management, LLC
5,346,119 (9.796%)
BlackRock Inc
4,599,278 (8.428%)
Eventide Asset Management, LLC
4,529,997 (8.301%)
Franklin Resources Inc
3,833,955 (7.025%)
Franklin Advisers, Inc.
3,747,508 (6.867%)
Cormorant Asset Management, LLC
3,250,000 (5.955%)
venBio Select Advisor LLC
3,150,000 (5.772%)
Avoro Capital Advisors LLC
3,150,000 (5.772%)
Jennison Associates LLC
2,959,161 (5.422%)
Cormorant Asset Management, LP
2,800,000 (5.131%)
Individual Holdings
Dr. Scott Braunstein, M.D.
223,512 (0.410%)
Mr. Steven Pfanstiel, C.M.A.,M.B.A.
71,697 (0.131%)
Mr. Joseph Hulihan
66,635 (0.122%)
Ms. Christina Shafer
60,308 (0.111%)
Ms. Martha E. Manning, Esq.
52,966 (0.097%)
Mr. Timothy M. Mayleben
22,075 (0.040%)
Dr. Sarah B. Noonberg, M.D.,PhD
11,800 (0.022%)
Ms. Christine Berni Silverstein
11,800 (0.022%)
Mr. Marvin H. Johnson, Jr
11,800 (0.022%)
Dr. Saraswathy V. Nochur, PhD
10,950 (0.020%)
Funds Holdings
Franklin Biotechnology Discovery Fund
2,546,727 (4.661%)
Vanguard US Total Market Shares ETF
1,525,656 (2.792%)
Vanguard Total Stock Market Index Fund
1,525,656 (2.792%)
iShares Russell 2000 ETF
1,239,952 (2.269%)
Vanguard Institutional Extnd Mkt Idx Tr
749,755 (1.372%)
Fidelity Small Cap Index Fund
509,191 (0.932%)
iShares Russell 2000 Growth ETF
449,488 (0.823%)
iShares Biotechnology ETF
395,932 (0.725%)
Fidelity Extended Market Index Fund
305,402 (0.559%)
Victory Science & Technology
272,254 (0.498%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
